• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VB-MK-LMF:使用变分贝叶斯多核逻辑矩阵分解融合药物、靶点及相互作用

VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization.

作者信息

Bolgár Bence, Antal Péter

机构信息

Department of Measurement and Information Systems, Budapest University of Technology and Economics, Magyar tudósok krt. 2., Budapest, 1117, Hungary.

出版信息

BMC Bioinformatics. 2017 Oct 4;18(1):440. doi: 10.1186/s12859-017-1845-z.

DOI:10.1186/s12859-017-1845-z
PMID:28978313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5628496/
Abstract

BACKGROUND

Computational fusion approaches to drug-target interaction (DTI) prediction, capable of utilizing multiple sources of background knowledge, were reported to achieve superior predictive performance in multiple studies. Other studies showed that specificities of the DTI task, such as weighting the observations and focusing the side information are also vital for reaching top performance.

METHOD

We present Variational Bayesian Multiple Kernel Logistic Matrix Factorization (VB-MK-LMF), which unifies the advantages of (1) multiple kernel learning, (2) weighted observations, (3) graph Laplacian regularization, and (4) explicit modeling of probabilities of binary drug-target interactions.

RESULTS

VB-MK-LMF achieves significantly better predictive performance in standard benchmarks compared to state-of-the-art methods, which can be traced back to multiple factors. The systematic evaluation of the effect of multiple kernels confirm their benefits, but also highlights the limitations of linear kernel combinations, already recognized in other fields. The analysis of the effect of prior kernels using varying sample sizes sheds light on the balance of data and knowledge in DTI tasks and on the rate at which the effect of priors vanishes. This also shows the existence of "small sample size" regions where using side information offers significant gains. Alongside favorable predictive performance, a notable property of MF methods is that they provide a unified space for drugs and targets using latent representations. Compared to earlier studies, the dimensionality of this space proved to be surprisingly low, which makes the latent representations constructed by VB-ML-LMF especially well-suited for visual analytics. The probabilistic nature of the predictions allows the calculation of the expected values of hits in functionally relevant sets, which we demonstrate by predicting drug promiscuity. The variational Bayesian approximation is also implemented for general purpose graphics processing units yielding significantly improved computational time.

CONCLUSION

In standard benchmarks, VB-MK-LMF shows significantly improved predictive performance in a wide range of settings. Beyond these benchmarks, another contribution of our work is highlighting and providing estimates for further pharmaceutically relevant quantities, such as promiscuity, druggability and total number of interactions.

摘要

背景

据报道,能够利用多种背景知识来源的药物-靶点相互作用(DTI)预测计算融合方法在多项研究中取得了卓越的预测性能。其他研究表明,DTI任务的特异性,如对观测值加权和关注辅助信息,对于达到最佳性能也至关重要。

方法

我们提出了变分贝叶斯多核逻辑矩阵分解(VB-MK-LMF)方法,该方法统一了以下优点:(1)多核学习;(2)加权观测值;(3)图拉普拉斯正则化;(4)对二元药物-靶点相互作用概率进行显式建模。

结果

与现有最先进的方法相比,VB-MK-LMF在标准基准测试中实现了显著更好的预测性能,这可追溯到多个因素。对多核效果的系统评估证实了它们的益处,但也凸显了线性核组合的局限性,这在其他领域已得到认可。使用不同样本量对先验核效果的分析揭示了DTI任务中数据与知识的平衡以及先验效果消失的速率。这也表明存在“小样本量”区域,在这些区域使用辅助信息能带来显著收益。除了良好的预测性能外,矩阵分解方法的一个显著特性是它们使用潜在表示为药物和靶点提供了一个统一的空间。与早期研究相比,这个空间的维度被证明出奇地低,这使得VB-ML-LMF构建的潜在表示特别适合视觉分析。预测的概率性质允许计算功能相关集合中命中的期望值,我们通过预测药物多效性来证明这一点。变分贝叶斯近似也在通用图形处理单元上实现,显著提高了计算时间。

结论

在标准基准测试中,VB-MK-LMF在广泛的设置下显示出显著提高的预测性能。除了这些基准测试外,我们工作的另一个贡献是突出并提供了对其他药学相关量的估计,如多效性、可成药性和相互作用总数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/ad0a91095cde/12859_2017_1845_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/33fc9ee29ace/12859_2017_1845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/2ea8ea72b892/12859_2017_1845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/0d56d3913489/12859_2017_1845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/8fd1abe87a70/12859_2017_1845_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/2e62e7180457/12859_2017_1845_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/0f57b4376878/12859_2017_1845_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/62f6bfde4aa2/12859_2017_1845_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/76a53b14bd55/12859_2017_1845_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/ad0a91095cde/12859_2017_1845_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/33fc9ee29ace/12859_2017_1845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/2ea8ea72b892/12859_2017_1845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/0d56d3913489/12859_2017_1845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/8fd1abe87a70/12859_2017_1845_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/2e62e7180457/12859_2017_1845_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/0f57b4376878/12859_2017_1845_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/62f6bfde4aa2/12859_2017_1845_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/76a53b14bd55/12859_2017_1845_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c8c/5628496/ad0a91095cde/12859_2017_1845_Fig9_HTML.jpg

相似文献

1
VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization.VB-MK-LMF:使用变分贝叶斯多核逻辑矩阵分解融合药物、靶点及相互作用
BMC Bioinformatics. 2017 Oct 4;18(1):440. doi: 10.1186/s12859-017-1845-z.
2
Kernelized Bayesian Matrix Factorization.核化贝叶斯矩阵分解。
IEEE Trans Pattern Anal Mach Intell. 2014 Oct;36(10):2047-60. doi: 10.1109/TPAMI.2014.2313125.
3
NMTF-DTI: A Nonnegative Matrix Tri-factorization Approach With Multiple Kernel Fusion for Drug-Target Interaction Prediction.NMTF-DTI:一种基于多核融合的非负矩阵三因子分解方法,用于药物-靶标相互作用预测。
IEEE/ACM Trans Comput Biol Bioinform. 2023 Jan-Feb;20(1):586-594. doi: 10.1109/TCBB.2021.3135978. Epub 2023 Feb 3.
4
Identification of drug-target interactions via multiple kernel-based triple collaborative matrix factorization.基于多核的三重协作矩阵分解识别药物-靶标相互作用。
Brief Bioinform. 2022 Mar 10;23(2). doi: 10.1093/bib/bbab582.
5
Kernel Bayesian nonlinear matrix factorization based on variational inference for human-virus protein-protein interaction prediction.基于变分推理的核贝叶斯非线性矩阵分解在人类-病毒蛋白质相互作用预测中的应用。
Sci Rep. 2024 Mar 8;14(1):5693. doi: 10.1038/s41598-024-56208-w.
6
A Bayesian Multiple Kernel Learning Algorithm for SSVEP BCI Detection.贝叶斯多内核学习算法在 SSVEP-BCI 检测中的应用。
IEEE J Biomed Health Inform. 2019 Sep;23(5):1990-2001. doi: 10.1109/JBHI.2018.2878048. Epub 2018 Oct 25.
7
Kernel-imbedded Gaussian processes for disease classification using microarray gene expression data.使用微阵列基因表达数据的用于疾病分类的核嵌入高斯过程。
BMC Bioinformatics. 2007 Feb 28;8:67. doi: 10.1186/1471-2105-8-67.
8
Drug-Target Interaction Prediction via Dual Laplacian Graph Regularized Logistic Matrix Factorization.通过双拉普拉斯图正则化逻辑矩阵分解进行药物-靶点相互作用预测
Biomed Res Int. 2021 Mar 26;2021:5599263. doi: 10.1155/2021/5599263. eCollection 2021.
9
Matrix factorization with denoising autoencoders for prediction of drug-target interactions.使用去噪自动编码器的矩阵分解进行药物-靶标相互作用的预测。
Mol Divers. 2023 Jun;27(3):1333-1343. doi: 10.1007/s11030-022-10492-8. Epub 2022 Jul 23.
10
Graph regularized non-negative matrix factorization with prior knowledge consistency constraint for drug-target interactions prediction.基于先验知识一致性约束的图正则化非负矩阵分解在药物-靶标相互作用预测中的应用。
BMC Bioinformatics. 2022 Dec 29;23(1):564. doi: 10.1186/s12859-022-05119-6.

引用本文的文献

1
Hybrid deep learning technique for COX-2 inhibition bioactivity detection against breast cancer disease.用于检测针对乳腺癌疾病的COX-2抑制生物活性的混合深度学习技术
Biomed Eng Lett. 2024 Apr 10;14(4):631-647. doi: 10.1007/s13534-024-00355-6. eCollection 2024 Jul.
2
Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation Study.基于时间疾病图谱的多中心评估调整多种疾病的残疾评分对抑郁相关风险的分层:仪器验证研究。
J Med Internet Res. 2024 Jun 24;26:e53162. doi: 10.2196/53162.
3
Graph regularized non-negative matrix factorization with [Formula: see text] norm regularization terms for drug-target interactions prediction.

本文引用的文献

1
Large-Scale Prediction of Drug-Target Interaction: a Data-Centric Review.大规模药物-靶标相互作用预测:以数据为中心的综述。
AAPS J. 2017 Sep;19(5):1264-1275. doi: 10.1208/s12248-017-0092-6. Epub 2017 Jun 2.
2
Deep-Learning-Based Drug-Target Interaction Prediction.基于深度学习的药物-靶点相互作用预测
J Proteome Res. 2017 Apr 7;16(4):1401-1409. doi: 10.1021/acs.jproteome.6b00618. Epub 2017 Mar 13.
3
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.
基于 [公式:见正文] 范数正则化项的图正则化非负矩阵分解在药物-靶标相互作用预测中的应用。
BMC Bioinformatics. 2023 Oct 3;24(1):375. doi: 10.1186/s12859-023-05496-6.
4
Graph regularized non-negative matrix factorization with prior knowledge consistency constraint for drug-target interactions prediction.基于先验知识一致性约束的图正则化非负矩阵分解在药物-靶标相互作用预测中的应用。
BMC Bioinformatics. 2022 Dec 29;23(1):564. doi: 10.1186/s12859-022-05119-6.
5
A Review of Current Methods for Repositioning Drugs and Chemical Compounds.药物和化合物重新定位的当前方法综述
Front Oncol. 2021 Jul 22;11:711225. doi: 10.3389/fonc.2021.711225. eCollection 2021.
6
Drug-target interaction prediction with tree-ensemble learning and output space reconstruction.基于树集成学习和输出空间重构的药物-靶标相互作用预测。
BMC Bioinformatics. 2020 Feb 7;21(1):49. doi: 10.1186/s12859-020-3379-z.
7
Machine learning approaches and databases for prediction of drug-target interaction: a survey paper.机器学习方法和数据库在药物-靶标相互作用预测中的应用:综述论文。
Brief Bioinform. 2021 Jan 18;22(1):247-269. doi: 10.1093/bib/bbz157.
SwissADME:一个免费的网络工具,用于评估小分子的药代动力学、类药性和药物化学友善性。
Sci Rep. 2017 Mar 3;7:42717. doi: 10.1038/srep42717.
4
SELF-BLM: Prediction of drug-target interactions via self-training SVM.SELF-BLM:通过自训练支持向量机预测药物-靶点相互作用
PLoS One. 2017 Feb 13;12(2):e0171839. doi: 10.1371/journal.pone.0171839. eCollection 2017.
5
Predicting drug-target interactions by dual-network integrated logistic matrix factorization.基于双网络集成逻辑矩阵分解的药物-靶标相互作用预测。
Sci Rep. 2017 Jan 12;7:40376. doi: 10.1038/srep40376.
6
Global vision of druggability issues: applications and perspectives.药物可及性问题的全球视野:应用与展望。
Drug Discov Today. 2017 Feb;22(2):404-415. doi: 10.1016/j.drudis.2016.11.021. Epub 2016 Dec 6.
7
The ChEMBL database in 2017.2017年的ChEMBL数据库。
Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. doi: 10.1093/nar/gkw1074. Epub 2016 Nov 28.
8
Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.用于高通量筛选中化合物库设计、命中筛选和生物活性建模的数据驱动方法。
Brief Bioinform. 2018 Mar 1;19(2):277-285. doi: 10.1093/bib/bbw105.
9
DrugE-Rank: improving drug-target interaction prediction of new candidate drugs or targets by ensemble learning to rank.DrugE-Rank:通过集成学习排序改进新候选药物或靶点的药物-靶点相互作用预测。
Bioinformatics. 2016 Jun 15;32(12):i18-i27. doi: 10.1093/bioinformatics/btw244.
10
How Reliable Are Ligand-Centric Methods for Target Fishing?以配体为中心的靶点筛选方法有多可靠?
Front Chem. 2016 Apr 14;4:15. doi: 10.3389/fchem.2016.00015. eCollection 2016.